Nutri-epigenetics ameliorates blood-brain barrier damage and neurodegeneration in hyperhomocysteinemia: role of folic acid

J Mol Neurosci. 2014 Feb;52(2):202-15. doi: 10.1007/s12031-013-0122-5.

Abstract

Epigenetic mechanisms underlying nutrition (nutrition epigenetics) are important in understanding human health. Nutritional supplements, for example folic acid, a cofactor in one-carbon metabolism, regulate epigenetic alterations and may play an important role in the maintenance of neuronal integrity. Folic acid also ameliorates hyperhomocysteinemia, which is a consequence of elevated levels of homocysteine. Hyperhomocysteinemia induces oxidative stress that may epigenetically mediate cerebrovascular remodeling and leads to neurodegeneration; however, the mechanisms behind such alterations remain unclear. Therefore, the present study was designed to observe the protective effects of folic acid against hyperhomocysteinemia-induced epigenetic and molecular alterations leading to neurotoxic cascades. To test this hypothesis, we employed 8-weeks-old male wild-type (WT) cystathionine-beta-synthase heterozygote knockout methionine-fed (CBS+/− + Met), WT, and CBS+/− + Met mice supplemented with folic acid (FA) [WT + FA and CBS+/− + Met + FA, respectively, 0.0057-μg g−1 day−1 dose in drinking water/4 weeks]. Hyperhomocysteinemia in CBS+/− + Met mouse brain was accompanied by a decrease in methylenetetrahydrofolate reductase and an increase in S-adenosylhomocysteine hydrolase expression, symptoms of oxidative stress, upregulation of DNA methyltransferases, rise in matrix metalloproteinases, a drop in the tissue inhibitors of metalloproteinases, decreased expression of tight junction proteins, increased permeability of the blood-brain barrier, neurodegeneration, and synaptotoxicity. Supplementation of folic acid to CBS+/− + Met mouse brain led to a decrease in the homocysteine level and rescued pathogenic and epigenetic alterations, showing its protective efficacy against homocysteine-induced neurotoxicity.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adenosylhomocysteinase / genetics
  • Adenosylhomocysteinase / metabolism
  • Animals
  • Blood-Brain Barrier / drug effects*
  • Blood-Brain Barrier / pathology
  • Cystathionine beta-Synthase / genetics
  • Diet
  • Epigenesis, Genetic*
  • Folic Acid / administration & dosage
  • Folic Acid / pharmacology
  • Folic Acid / therapeutic use*
  • Heterozygote
  • Hyperhomocysteinemia / diet therapy*
  • Hyperhomocysteinemia / genetics
  • Hyperhomocysteinemia / metabolism
  • Matrix Metalloproteinases / genetics
  • Matrix Metalloproteinases / metabolism
  • Methionine / administration & dosage
  • Methionine / pharmacology
  • Methylenetetrahydrofolate Reductase (NADPH2) / genetics
  • Methylenetetrahydrofolate Reductase (NADPH2) / metabolism
  • Methyltransferases / genetics
  • Methyltransferases / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Neuroprotective Agents / administration & dosage
  • Neuroprotective Agents / pharmacology
  • Neuroprotective Agents / therapeutic use*
  • Oxidative Stress

Substances

  • Neuroprotective Agents
  • Folic Acid
  • Methionine
  • Methylenetetrahydrofolate Reductase (NADPH2)
  • Methyltransferases
  • Adenosylhomocysteinase
  • Matrix Metalloproteinases
  • Cystathionine beta-Synthase